These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10936809)

  • 1. Oxidant stress in hemodialysis: prevention and treatment strategies.
    Wratten ML; Tetta C; Ursini F; Sevanian A
    Kidney Int Suppl; 2000 Aug; 76():S126-32. PubMed ID: 10936809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
    Himmelfarb J
    Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress in hemodialysis patients: what are the determining factors?
    Ward RA; McLeish KR
    Artif Organs; 2003 Mar; 27(3):230-6. PubMed ID: 12662208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and inflammation: Implications in uremia and hemodialysis.
    Libetta C; Sepe V; Esposito P; Galli F; Dal Canton A
    Clin Biochem; 2011 Oct; 44(14-15):1189-98. PubMed ID: 21777574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestations of oxidant stress in uremia.
    Himmelfarb J; McMonagle E
    Blood Purif; 2001; 19(2):200-5. PubMed ID: 11150810
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of oxidative and carbonyl stress to long-term uremic complications.
    Miyata T; Kurokawa K; van Ypersele de Strihou C
    Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients.
    Piroddi M; Depunzio I; Calabrese V; Mancuso C; Aisa CM; Binaglia L; Minelli A; Butterfield AD; Galli F
    Amino Acids; 2007; 32(4):573-92. PubMed ID: 17356806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis on the oxidative stress and antioxidants.
    Dursun E; Ozben T; Süleymanlar G; Dursun B; Yakupoglu G
    Clin Chem Lab Med; 2002 Oct; 40(10):1009-13. PubMed ID: 12476939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
    Dursun E; Dursun B; Süleymanlar G; Ozben T
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative stress: an accomplice to uremic toxicity?
    Mircescu G
    J Ren Nutr; 2006 Jul; 16(3):194-8. PubMed ID: 16825018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein homeostasis in chronic hemodialysis patients.
    Pupim LB; Flakoll PJ; Ikizler TA
    Curr Opin Clin Nutr Metab Care; 2004 Jan; 7(1):89-95. PubMed ID: 15090908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adequate dialysis].
    Maduell Canals F
    Nefrologia; 2002; 22(2):111-34. PubMed ID: 12085413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protein-bound uremic toxins: efficacy of elimination during hemodialysis and CAPD].
    Krajewska M; Weyde W; Klinger M
    Pol Arch Med Wewn; 2003 Apr; 109(4):411-5. PubMed ID: 12931494
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular aspects of T- and B-cell function in uremia.
    Girndt M; Sester M; Sester U; Kaul H; Köhler H
    Kidney Int Suppl; 2001 Feb; 78():S206-11. PubMed ID: 11169012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxidative stress, hemo-incompatibility and complications of long-term dialysis].
    Morena M; Martin-Mateo M; Cristol JP; Canaud B
    Nephrologie; 2002; 23(5):201-8. PubMed ID: 12227252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
    Miyata T; Sugiyama S; Saito A; Kurokawa K
    Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
    Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis holds distinct advantages for 21st century uremia therapy.
    Nose Y; Smith JW; Malchesky PS
    Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.